Page 9 - Double Blind News Today

MyJournals.org - Science - Brain‐oscillation-synchronized stimulation to enhance motor recovery in early subacute stroke: a randomized controlled double‐blind three‐ arm parallel‐group exploratory trial comparing personalized, non‐ personalized and sham repetitive transcranial magnetic stimulation (Acronym: BOSS-STROKE) (BMC Neurology)

Pollyanna McIntosh is well known in The Walking Dead universe for her portrayal of Anne/Jadis, she has a new project Quicksand.

Misty Mountain Studio and Neon Doctrine have a new demo available for LudoNarraCon 2023, as you can try out Death Trick: Double Blind.

/PRNewswire/ -- Cellenkos® Inc., a clinical stage biotechnology company focused on developing allogeneic, off-the-shelf, T regulatory cell therapies for...

New Delhi [India], April 28 (ANI/SRV): A study by Indian nutraceutical major Meyer Vitabiotics has revealed that a combination of anti-oxidant micronutrients and vitamins improved male fertility parameter by 76 per cent even in severe cases of male infertility. Among Indian males with baseline sperm count of less than 5 million / ml, a blend of multi-vitamins, minerals, essential amino acids, ginseng & lycopene increased the sperm count by 75.76 percent. The study was conducted over a 3-mont...

Gurgaon (Haryana) [India], April 14 (ANI/BusinessWire India): Art of Healing Cancer, a globally renowned Precision and integrative oncology institution located in Gurgaon, underscores the possible benefits of incorporating the anti-malarial drug, Artesunate, into cancer treatments

MyJournals.org - Science - Improved social functioning and role functioning in rheumatic patients using a non-verbal communication tool: Results from a randomized, double-blind, controlled pilot-study (Frontiers in Medicine)

Physical symptoms of stress on the body are varied, ranging from hormonal changes to changes in the nervous system, manifesting as the flight-fight-freeze response.

The significant improvements in scalp hair regrowth were achieved at 24 weeks for patients taking 8 mg twice-daily and 12 mg twice-daily doses of deuruxolitinib.

Three lawmakers are looking to pass the bill in the state this year.